Insider tradingForm 4
Opus Genetics, Inc. (IRD) Insider Trading
6 open-market trades reported since Sep 8, 2026: 0 purchases worth $0 and 6 sales worth $3.10M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Benjamin R. Yerxa | President | 0 | $0 | 1 | $117K |
| Robert E. Gagnon | CFO | 0 | $0 | 2 | $177K |
| George Magrath | CEO | 0 | $0 | 1 | $34K |
| Joseph K. Schachle | COO | 0 | $0 | 1 | $17K |
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | 0 | $0 | 1 | $2.76M |
ADVERTISEMENT
320 × 100 ad slot
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 27 | Benjamin R. YerxaPresident | ▼ SELL | $117K | |
| Oct 27 | Robert E. GagnonCFO | ▼ SELL10b5-1 | $50K | |
| Oct 27 | George MagrathCEO | ▼ SELL | $34K | |
| Oct 27 | Joseph K. SchachleCOO | ▼ SELL | $17K | |
| Oct 2 | Foundation Fighting Blindness Retinal Degeneration FundDirector | ▼ SELL | $2.76M | |
| Sep 8 | Robert E. GagnonCFO | ▼ SELL | $127K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings